Medication info
Olmesartan Medoxomil 20 mg Tablets

Olmesartan Medoxomil 20 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Il Dong Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201306919 · Approved 2013.04.16 · Insurance code 642904790

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after treatment is started and reaches its maximum after approximately 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be used in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, a more pronounced response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.
Child dose
The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Il Dong Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension occurs without a specific cause, and treatment is necessary to maintain blood pressure within the normal range. This medication helps lower blood pressure by dilating blood vessels and reducing the burden on the heart, thereby helping to prevent complications. Regular use contributes to cardiovascular health and aids in the regulation of normal blood pressure. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, administered with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is required, the dose may be increased to a maximum of 40mg once daily. The blood pressure-lowering effect appears within 2 weeks after treatment is started and reaches its maximum after approximately 8 weeks. If blood pressure is not adequately controlled with this medicine alone, it may be used in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be initiated at a low dose while their condition is closely monitored. <Elderly patients> No dose adjustment is necessary when this medicine is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, a more pronounced response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg once daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended.

Child dose

The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause serious harm or death to the fetus and newborn if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. Individuals with allergies to any of the ingredients in this medication, pregnant or nursing women, patients on renal dialysis, those with severe liver impairment, patients with bile duct obstruction, and certain hereditary lactose intolerant patients should not take this medication. Patients with decreased blood volume or insufficient sodium may experience low blood pressure, so their condition should be thoroughly evaluated before use, and prompt treatment should be sought if symptoms of low blood pressure occur. Patients with impaired kidney function or kidney transplant recipients should have their serum potassium and creatinine levels monitored regularly, and it is not recommended for patients with severe renal impairment. This medication has blood pressure-lowering effects, so caution is required for patients with aortic stenosis or mitral valve stenosis, and it may be less effective in patients with primary aldosteronism. Dizziness may occur during treatment, so it is advisable to avoid hazardous activities such as working at heights or driving. During treatment, caution should be taken when using potassium-sparing diuretics, potassium supplements, lithium, or non-steroidal anti-inflammatory drugs, as the risk of side effects may increase. Consult with a doctor regarding these combinations. If chronic diarrhea or weight loss occurs, this medication may be the cause, and immediate consultation with a healthcare professional is advised, and appropriate treatment should be sought if intestinal vascular edema symptoms develop. The safety and efficacy in pediatric patients have not been thoroughly established, and elderly patients may experience increased drug concentrations in the body, necessitating caution. Overdose may result in low blood pressure or palpitations; if symptoms are severe, immediate medical attention is required. Regular liver function and blood tests during treatment are important to detect and manage adverse reactions early. Nursing mothers should consult a doctor about the possibility of the drug being transmitted through breast milk and consider stopping breastfeeding or discontinuing the medication.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • dyspepsia
  • gastroenteritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • asthenia
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • headache
  • increased blood pressure
  • epistaxis
  • asthma
  • position-related dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to protect it from air and moisture. It should be stored at room temperature, between approximately 1 degree and 25 degrees Celsius, away from extreme temperatures.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.